Previous Article | Next Article 
Journal of Clinical Microbiology, October 2005, p. 5327-5331, Vol. 43, No. 10
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.10.5327-5331.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Sequence-Based Typing of adeB as a Potential Tool To Identify Intraspecific Groups among Clinical Strains of Multidrug-Resistant Acinetobacter baumannii
Geert Huys,1*
Margo Cnockaert,1
Alexandr Nemec,2,3 and
Jean Swings1,4
Laboratory of Microbiology,1
BCCM/LMG Bacteria Collection, Ghent University, K. L. Ledeganckstraat 35, Ghent, Belgium,4
National Institute of Public Health,2
Department of Medical Microbiology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic3
Received 20 May 2005/
Returned for modification 20 June 2005/
Accepted 22 July 2005

ABSTRACT
Sequence
analysis of an 850-bp fragment internal to the aspecific
drug efflux
gene
adeB revealed 11 sequence types (STs) among
a collection
of 50 multidrug-resistant
Acinetobacter baumannii (MDRAB)
strains, including members of pan-European clones I,
II, and III. The
delineation of STs conformed with the intraspecific
grouping of these
strains previously determined by different
DNA fingerprinting methods.
Larger strain collections need to
be screened to further explore the
potential of sequence-based
adeB typing as a universal tool
for the monitoring of MDRAB
clones.

TEXT
Acinetobacter baumannii is one of the most frequently isolated
nonfermentative
gram-negative species from critically ill and
immunocompromised
patients among intensive care units patients
worldwide. Strains
of this opportunistic pathogen can be involved in a
range of
nosocomial infections, such as ventilator-associated
pneumonia,
bloodstream infections, and meningitis
(
1), and are acquiring
resistance
to multiple antibiotics at an increasing rate
(
4,
9).
A. baumannii
infections
can occur as sporadic cases associated with single genotypes
but
can also give rise to epidemic outbreaks caused by genotypically
highly
related isolates, such as those belonging to the
pan-European
(pE) multidrug-resistant
A. baumannii
(MDRAB) clones I, II,
and III
(
3,
18). Thus far, the
intraspecific differentiation
of MDRAB has mainly relied on the single
or combined use of
DNA fingerprinting methods, including ribotyping,
amplified
fragment length polymorphism (AFLP) analysis, pulsed-field
gel
electrophoresis (PFGE) of macrorestriction fragments, and
repetitive
DNA element PCR (rep-PCR)
(
2,
3,
7,
8,
13,
18). Apart from
differences
in genotypic resolution, labor intensity, and
reproducibility,
all these techniques share the major drawback that
interlaboratory
comparison remains problematic because fingerprinting
data are
generally not portable. DNA sequence-based methods, on the
other
hand, facilitate unambiguous and global comparisons of the
findings
between different laboratories and are expected to outcompete
banding
pattern-based methods in long-term epidemiological studies
(
17).
As opposed to other
human pathogens, however, the search for
genes that can be used in
single or multilocus sequence typing
(MLST;
http://www.mlst.net)
at the intraspecific or strain level
is ongoing for
A.
baumannii. In previous papers
(
7,
8,
15),
we reported that
members of pan-European MDRAB clones I, II,
and III as well as a number
of genotypically unrelated MDRAB
strains all shared the aspecific drug
efflux gene
adeB, together
with various combinations of genes
that specifically confer
resistance to aminoglycosides (AGs) and
tetracyclines. The
adeB gene makes up part of the
adeABC gene cluster, which encodes
a
resistance-nodulation-cell division-type three-component efflux
system
that was recently described for
A. baumannii strain BM4454
(
10).
In this strain,
adeABC conferred low-level resistance to several
aminoglycosides
and reduced susceptibilities to various other
antimicrobial
agents. Triggered by the observation that the
adeB gene was
present in a set of genotypically related and
unrelated MDRAB
strains from different geographical origins and time
periods,
the current study set out to investigate whether
adeB
is a suitable
locus for sequence-based identification of intraspecific
groups
among MDRAB strains.
For the purpose of this study, 50
well-documented MDRAB strains mostly from European hospitals were
selected from previous studies in which they were typed by one or
multiple DNA fingerprinting methods and in which it was shown that they
contained the adeB gene (Table
1). This selection included members of pE clones I, II, and III but also
clinical strains from the Czech Republic previously allocated to three
ribotypes, five genotypically unrelated clinical strains, and
veterinary isolate LMG 22458. Most of the MDRAB selected strains were
resistant to one or multiple aminoglycosides (Table
1), to several
fluoroquinolones (18),
and to tetracycline (7,
8). Susceptibility to
aminoglycosides was determined by the disk diffusion method
with BBL Mueller-Hinton II agar (Becton Dickinson and Company),
according to the recommendations of CLSI (formerly NCCLS)
(12), by using the
following disks (Oxoid Ltd., Basingstoke, United Kingdom): kanamycin
(30 µg), gentamicin (10 µg), tobramycin (10
µg), amikacin (30 µg), and netilmicin (30 µg).
Total genomic DNA was prepared by using a protocol based on the method
of Pitcher and coworkers
(16). For adeB
detection, a common PCR core mix (total volume, 50 µl) was used
that consisted of 1x PCR buffer (Applied Biosystems,
Warrington, United Kingdom), deoxynucleoside triphosphates (dNTPs;
Applied Biosystems) at a concentration of 200 µM of each dNTP,
1 U of AmpliTaq DNA polymerase (Applied Biosystems), and 20
pmol of each primer (Sigma-Genosys Ltd., Cambridgeshire, United
Kingdom). A 50-ng portion of intact total DNA was used as the PCR
template. Detection and partial sequence analysis of adeB were
performed with the previously published PCR primer pair O3
(5'-GTATGAATTGATGCTGC-3') and O4
(5'-CACTCGTAGCCAATACC-3') that
targets a 979-bp fragment internal to this gene in A.
baumannii strain BM4454, which was used as a positive control in
PCR (10). PCR
amplifications were performed in a GeneAmp 9600 PCR system
(Perkin-Elmer) by using the following temperature program: initial
denaturation at 94°C for 5 min; 25 cycles of denaturation at
94°C for 30 s, annealing at 55°C for 1 min,
and extension at 72°C for 1 min; and a final extension at
72°C for 7 min. Partial sequencing of adeB positions
1635 to 2484 was performed by using the BigDye Terminator (version 3.1)
ready reaction cycle sequencing kit on an ABI Prism 3100 genetic
analyzer (Applied Biosystems). As a control, the sequence of the
internal adeB fragment of A. baumannii strain BM4454
(EMBL accession no.
AF370885)
(10) was redetermined.
Sequence alignments and comparisons were performed by using BioNumerics
software (version 3.5; Applied Maths, St.-Martens Latem, Belgium) and
the BioEditor program
(5).
In the present
study, the previously designed primer pair O3-O4
(
10)
was used for
sequence analysis of an internal region of the
adeB gene in
order to investigate whether this gene contains
polymorphic sites that
are potentially useful for sequence-based
identification of
intraspecific groups in MDRAB. As a result
of this partial sequencing
approach, 11 different
adeB sequence
types (STs; STs I to XI)
could be defined (Fig.
1) among a collection
of 50 MDRAB strains representing six previously
delineated intraspecific
groups and five genotypically unrelated
strains. By definition,
an
adeB gene was considered to
represent a distinct ST when
its 850-bp partial sequence differed in at
least one position
from all other sequences. STs that were shared by
two or more
strains (i.e., STs I to VI) all displayed a complete
internal
sequence identity, whereas the number of base conversions
between
individual STs ranged from 2 to 45 (Fig.
1). Although the majority
of
these conversions were found to represent silent mutations,
a number
of substitutions resulted in amino acid sequence polymorphisms
(Table
2). The polymorphic sites at positions 551, 584, 606,
and 730 may be of
diagnostic value for discrimination of pE
clones I, II, and III; but
clearly, more strains of these intraspecific
MDRAB groups need to be
investigated to verify this finding.
The partially redetermined
nucleotide sequence of the
adeB gene
of strain BM4454
(
10) differed from the
original sequence (EMBL
accession no.
AF370885)
at two positions, i.e., positions 1974
and 2295, where in both cases
the sequence representing ST II
(EMBL accession no.
AJ971416)
contained an A instead of a G.
The delineation of the 11
adeB STs completely agreed with the
intraspecific diversity
among the 50 MDRAB strains previously
assessed by DNA fingerprinting
methods such as ribotyping, AFLP
analysis, PFGE, and/or rep-PCR. The
most remarkable finding
was that all members of pE clones I (
n
= 16), II (
n = 13), and
III (
n
= 10) belonged to the same
adeB ST, i.e., STs I, II,
and
III, respectively (Table
1). The strains of pE
clones I, II,
and III included for this study were selected in a way
that
they represented hospital units from four to six different
European
countries and that they were isolated at different time points
during
the past 20 years. The fact that members of a given pE clone
with
different geographical and/or temporal histories all shared
the
same
adeB ST thus indicates that sequence-based typing of
this
gene may be a potential tool for the quick identification
of new
members of these widespread clones. As evidenced by the
data obtained
with the Czech MDRAB strains previously allocated
to HindIII-HincII
ribotyping groups R21-16 and R23-19 and, accordingly,
also grouped in
two AFLP clusters (
13)
(Table
1), partial
adeB sequencing may also have the potential to identify less
widespread
intraspecific MDRAB groups. The two representative strains
of
both groups displayed an identical
adeB ST; and the two
corresponding
STs, STs V and VI, appeared to be unique and clearly
distinct
from STs I to III (Fig.
1). Interestingly, strains
NIPH 1717
and NIPH 301, which were previously assigned to the highly
related
ribotypes R2-6 and R2-7 and that grouped in the
same AFLP cluster
(
13),
were also joined together by
adeB typing as members of
ST IV
(Table
1). The finding
that the five genotypically unrelated
MDRAB strains from the Czech
Republic, the United Kingdom, and
Brazil (Table
1) each exhibited a unique
adeB ST may indicate
that these strains represent distinct
intraspecific lineages
in
A. baumannii (Fig.
1); but further evidence,
e.g., evidence
based on MLST, is awaited to substantiate this. The fact
that
strains AC 658 and NIPH 1734, which represent the closely related
adeB STs IX and X (Fig.
1), respectively, also
displayed highly similar
but not identical (GTG)
5-PCR band
patterns (G. Huys, unpublished
data) again illustrates the good overall
agreement found between
the
adeB sequence-based grouping and
the intraspecific grouping
based on DNA fingerprinting. On the other
hand, our sequencing
data also indicate that the 850-bp region of the
adeB gene analyzed
in this study is probably not variable
enough to discriminate
MDRAB strains at the subclonal level. For
example, clone II
strains NIPH 1469 and RUH 3240 shared a ribotype
(ribotype R4-2)
slightly different from the other clone II ribotypes
and grouped
in a distinct AFLP subcluster of clone II
(
13), and yet, both
strains
belonged to ST II (Table
1). Possibly, sequencing
of longer
or multiple fragments of
adeB or other components of
the
adeABC gene cluster may increase the resolution of the
method.
At present, little is known about the distribution and
evolutionary history of the adeB gene in A.
baumannii. So far, the gene has mainly been detected in A.
baumannii outbreak strains
(6,
7,
8) that exhibit resistance
to multiple drugs, usually including one or more AGs. Recently, it was
found that adeB can be up-regulated in MDRAB
(6) and that it can also
occur in drug-susceptible A. baumannii strains
(15), in which the gene
may be cryptic due to the regulatory control by the two-component AdeRS
system (11). Because of
this stringent control, it is difficult to predict the presence of
adeB in A. baumannii based on the AG resistance
profile. In addition, many European MDRAB strains are known to carry
one or several specific AG resistance genes
(14) that can potentially
reinforce the AG resistance spectrum encoded by adeB. This
effect is highly pronounced for pE clones I and II, in which the AG
resistotypes differed significantly among adeB-positive
strains (Table 1). In the
course of a PCR-based screening survey for adeB in 32
environmental A. baumannii isolates of aquatic and terrestrial
origins, it was found that none of the strains investigated harbored
the efflux gene (Huys, unpublished). Provided that the use of
additional (degenerated) primer sets confirm these findings, this
suggests that the gene is probably not omnipresent in A.
baumannii and was acquired by a number of strains from an
exogenous source at some point in time. For this reason, it is expected
that adeB typing will primarily be useful for clinical
isolates of this species.
Based on partial sequencing analysis,
the present study has demonstrated that the delineation of
adeB STs among genotypically related and unrelated MDRAB
strains corroborated extremely well the genotypic clustering of these
strains previously obtained with various banding pattern-based methods.
However, it is clear that more extended collections of clinical and
environmental isolates need to be investigated in order to obtain
better insight into the distribution of the adeB gene among
A. baumannii strains and to further validate the use of
adeB typing for the rapid identification of known
intraspecific groups or the delineation of new intraspecific lineages
in this species. When it is integrated in a dynamic Internet-based
platform, sequence-based typing of adeB could prove to be a
useful tool for worldwide monitoring of MDRAB
clones.
Nucleotide sequence accession numbers.
A selection of the
sequences representing the 11 adeB sequence types reported in
this study have been submitted to EMBL under accession numbers
AJ971415
to
AJ971425
(Fig.
1).

ACKNOWLEDGMENTS
G.H. is a postdoctoral fellow of the Fund for
Scientific Research-Flanders
(Belgium) (F.W.O.-Vlaanderen). A.N. was
supported by grant 8554-3
of the Internal Grant Agency of the Ministry
of Health of the
Czech Republic.
We thank L. Dijkshoorn, N.
Woodford, M. Vaneechoutte, S. Brisse, and V. Magalhães for the
kind gifts of strains. P. Dawyndt is acknowledged for excellent
assistance in sequence data
processing.

FOOTNOTES
* Corresponding author. Mailing address: Laboratory of Microbiology, Ghent University,
K. L. Ledeganckstr. 35, B-9000 Gent, Belgium. Phone: 0032 9 2645131. Fax: 0032 9 2645092. E-mail:
geert.huys{at}UGent.be.


REFERENCES
1 - Bergogne-Bérézin,
E., and K. J. Towner. 1996.
Acinetobacter spp. as nosocomial pathogens: microbiological,
clinical, and epidemiological features. Clin. Microbiol.
Rev.
9:148-165.[Medline]
2 - Bou,
G., G. Cervero, M. A. Dominguez, C. Quereda, and J.
Martinez-Beltran. 2000. PCR-based DNA fingerprinting
(REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization
of a nosocomial outbreak caused by imipenem- and meropenem-resistant
Acinetobacter baumannii. Clin. Microbiol.
Infect.
6:635-643.[CrossRef][Medline]
3 - Dijkshoorn,
L., H. Aucken, P. Gerner-Smidt, P. Janssen, M. E. Kaufmann,
J. Garaizar, J. Ursing, and T. L. Pitt.1996
. Comparison of outbreak and nonoutbreak
Acinetobacter baumannii strains by genotypic and phenotypic
methods. J. Clin. Microbiol.
34:1519-1525.[Abstract]
4 - Gales,
A. C., R. N. Jones, K. R. Forward, J.
Linares, H. S. Sader, and J. Verhoef. 2001.
Emerging importance of multidrug-resistant Acinetobacter
species and Stenotrophomonas maltophilia as pathogens in
seriously ill patients: geographic patterns, epidemiological features,
and trends in the SENTRY Antimicrobial Surveillance Program
(1997-1999). Clin. Infect. Dis.
32(Suppl.
2):S104-S113.
5 - Hall,
T. A. 1999. BioEdit: a user-friendly
biological sequence alignment editor and analysis program for Windows
95/98/NT. Nucleic Acids Symp. Ser.
41:95-98.
6 - Higgins,
P. G., H. Wisplighoff, D. Stefanik, and H. Seifert.2004
. Selection of topoisomerase mutations and
overexpression of adeB mRNA transcripts during an outbreak of
Acinetobacter baumannii. J. Antimicrob.
Chemother.
54:821-823.[Abstract/Free Full Text]
7 - Huys, G., M. Cnockaert, A. Nemec, L. Dijkshoorn, S. Brisse, M. Vaneechoutte, and J. Swings. 2005. Repetitive-DNA-element PCR fingerprinting and antibiotic resistance of pan-European multi-resistant Acinetobacter baumannii clone III strains. J. Med. Microbiol. 54:851-856.[Abstract/Free Full Text]
8 - Huys,
G., M. Cnockaert, M. Vaneechoutte, N. Woodford, A. Nemec, L.
Dijkshoorn, and J. Swings. 2005. Distribution of
tetracycline resistance genes in genotypically related and unrelated
multi-resistant Acinetobacter baumannii strains from different
European hospitals. Res. Microbiol.
156:348-355.[Medline]
9 - Karlowsky,
J. A., D. C. Draghi, M. E. Jones, C.
Thornsberry, I. R. Friedland, and D. F. Sahm.2003
. Surveillance for antimicrobial susceptibility among
clinical isolates of Pseudomonas aeruginosa and
Acinetobacter baumannii from hospitalized patients in the
United States, 1998 to 2001. Antimicrob. Agents
Chemother.
47:1681-1688.[Abstract/Free Full Text]
10 - Magnet,
S., P. Courvalin, and T. Lambert. 2001.
Resistance-nodulation-cell division-type efflux pump involved in
aminoglycoside resistance in Acinetobacter baumannii strain
BM4454. Antimicrob. Agents Chemother.
45:3375-3380.[Abstract/Free Full Text]
11 - Marchand,
I., L. Damier-Piolle, P. Courvalin, and T. Lambert.2004
. Expression of the RNA-type efflux pump AdeABC in
Acinetobacter baumannii is regulated by the AdeRS
two-component system. Antimicrob. Agents Chemother.
48:3298-3304.[Abstract/Free Full Text]
12 - National
Committee for Clinical Laboratory Standards. 2000.
Performance standards for antimicrobial disk susceptibility testing.
Approved standard M2-A7. National Committee for Clinical Laboratory
Standards, Wayne,
Pa.
13 - Nemec, A.,
L. Dijkshoorn, and T. J. K. van der Reijden.2004
. Long-term predominance of two pan-European clones
among multi-resistant Acinetobacter baumannii strains in the
Czech Republic. J. Med. Microbiol.
53:147-153.[Abstract/Free Full Text]
14 - Nemec,
A., L. Dolzani, S. Brisse, P. van den Broek, and L. Dijkshoorn.2004
. Diversity of aminoglycoside-resistance genes and
their association with class 1 integrons among strains of pan-European
Acinetobacter baumannii clones. J. Med.
Microbiol.
53:1233-1240.[Abstract/Free Full Text]
15 - Nemec,
A., and M. Maixnerová. 2004. Aminoglycoside
resistance of Acinetobacter baumannii hospital strains in the
Czech Republic. Klin. Mikrobiol. Infekc. Lek.
10:223-228.[Medline]
16 - Pitcher,
D. G., N. A. Saunders, and R. J.
Owen. 1989. Rapid extraction of bacterial genomic DNA
with guanidium thiocyanate. Lett. Appl. Microbiol.
8:151-156.
17 - Urwin,
R., and M. C. Maiden. 2003. Multi-locus
sequence typing: a tool for global epidemiology. Trends
Microbiol.
11:479-487.[CrossRef][Medline]
18 - van
Dessel, H., L. Dijkshoorn, T. Van der Reijden, N. Bakker, A. Paauw, P.
Van den Broek, J. Verhoef, and S. Brisse. 2004.
Identification of a new geographically widespread multiresistant
Acinetobacter baumannii clone from European hospitals.Res. Microbiol.
155:105-112.[Medline]
Journal of Clinical Microbiology, October 2005, p. 5327-5331, Vol. 43, No. 10
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.10.5327-5331.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Ruzin, A., Keeney, D., Bradford, P. A.
(2007). AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Antimicrob Chemother
59: 1001-1004
[Abstract]
[Full Text]
-
Ecker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T.-T. D., Agasino Ivy, C., Blyn, L. B., Hofstadler, S. A., Endy, T. P., Scott, P. T., Lindler, L., Hamilton, T., Gaddy, C., Snow, K., Pe, M., Fishbain, J., Craft, D., Deye, G., Riddell, S., Milstrey, E., Petruccelli, B., Brisse, S., Harpin, V., Schink, A., Ecker, D. J., Sampath, R., Eshoo, M. W.
(2006). Identification of Acinetobacter Species and Genotyping of Acinetobacter baumannii by Multilocus PCR and Mass Spectrometry.. J. Clin. Microbiol.
44: 2921-2932
[Abstract]
[Full Text]